Download CURRICULUM VITAE

CURRICULUM VITAE
NAME
Mototsugu Oya, M.D.
IDENTICAL INFORMATION
Title: Professor and Chairman, Department of Urology,
Keio University School of Medicine
E-mail: [email protected]
EDUCATIONAL HISTORY
Sep/1994
Mar/1987
Doctor of Medical Science. Keio University, School of
Medicine,Tokyo, Japan
M.D. Keio University, School of Medicine, Tokyo, Japan
PROFESSIONAL BACKGROUND (EMPLOYMENT HISTORY)
Oct/2013:-present
Aug/2007-present
Vice Director, Keio University Hospital
Professor and Chairman, Department of Urology,
Keio University School of Medicine
Apr/2001-Jul/2007
Assistant Professor, Department of Urology,
Keio University School of Medicine
(Aug/2004-Jul/2006 Program Officer, Ministry of Education, Culture, Sports,
Science and Technology)
Oct/1998-Mar/2001 Medical Staff, Department of Urology,
Keio University Hospital
Jan/1997-Sep/1998 Postdoctoral fellow, Department of Urology,
Duesseldorf University, Germany
Apr/1996-Oct/1996 Medical Staff, Division of Urology, Ogikubo Hospital, Tokyo
Jan/1995-Mar/1996 Postdoctoral fellow, Department of Urology, New York
Medical College, USA
Jun/1993-Nov/1994 Medical Staff, Division of Urology, Saiseikai Chuou Hospital, Tokyo
Jun /1987-May/1993 Resident atDepartment of Urology, Keio University Hospital
Jun/1987:
passed the Examination of National Board
LICENSE AND CERTIFICATION
1987
1993
2003
2003
2008
2008
Japanese
Japanese
Japanese
Japanese
Japanese
Japanese
Medical License Registration
Board of Urology, Certified Urologist
Board of Nephrology, Certified Doctor
Board of Dialysis Medicine, Certified Doctor
Board of Cancer Treatment, Certified Doctor
Society of Endourology & ESWL , Certified Laparoscopic Surgeon
MEMBERSHIP (selected)
Japanese Urological Association (director)
Japanese Society of Cancer (councilor)
Japanese Society of Clinical Oncology (councilor)
Japanese Society of Endourology and ESWL (councilor)
Japanese Society of Nephrology (councilor)
Japanese Society of Dialysis Medicine
SociétéInternationale d’Urologie
American Urological Association
European Association of Urology
PRIZE
Japanese Urological Association Prize 2005
Organon Urological Research Grant 2006
Japanese Urological Association Research Grant 2011
SPECIALIZED FIELDS
Urology, Oncology, Nephrology, Dialysis, Cancer Biology, Immunology,
Molecular Medicine
EDITORIALES FOR SPECIFIC JOURNALES
International Journal of Urology (Editor-in-Chief)
Cancer Science (Associated editor)
International Case Conference Journal (Associated editor)
Clinical and Experimental Nephrology (Associate editor)
World Journal of Urology(Editor)
International Journal Clinical Oncology (Editor)
Japanese Journal of Clinical Oncology (Editor)
Japanese Journal of Urology (Editor-in-Chief)
Japanese Journal of Clinical Urology (Editor-in-Chief)
Japanese Journal ofDialysis Medicine (Associate editor)
BIBLIOGRAPHY: PUBLICATIONS
1. Oya M: Antitumor effect of interleukin-2 entrapped in liposomes on murine renal cell carcinoma: Keio
J Med, 43, 37-44, 1994.
2. Oya M, Nakamura K, Baba S, Hata J, Tazaki H: Intrarenal satellites of renal cell carcinoma: Histopathological
manifestation and clinical implication: Urology, 46, 161-164, 1995.
3. Baba S, Asanuma H, Oya M: Laparoscopy assisted orchiopexy. –Technical feasibility and indications– Jpn
J EVndourol: ESWL, 8, 144-147, 1995.
4. Oya M, Marumo K, Murai M, Tazaki H: Pharmacokinetics and antitumor effects of an interleukin-2
immunocomplexing agent in murine renal cell carcinoma: Int J Urol, 3, 141-144, 1996.
5. Marumo K, Oya M, Murai M, Tazaki H: Application of cytokine drug delivery systems to the immunotherapy
of renal cell carcinoma: Int J Urol, 3, s24-s27, 1996.
6. Oya M, Konno S, Chen Y, Tazaki H, Mallouh C, Wu J. M: Control of cell cycle regulatory proteins andmodulation
of STAT1 proteins by IFN-γ in human prostatic JCA-1 cells: Int J Oncol, 10, 835-839, 1997.
7. Marumo K, Oya M, Murai M: Application of interferon minipellet to human renal cell carcinoma in nude
mice: Int J Urol, 4, 55-61, 1997.
8. Marumo K, Oya M, Murai M: Biochemical modulation of 5-fluorouracil with murine interferon–α/βagainst
murine renal cell carcinoma: Int J Urol, 4, 163-168, 1997.
9. Oya M, Schmidt B, Schmitz-Dräger B.J, Schulz.W. A: Expression of G1S transition regulatory molecules
in human urothelial cancer: Jpn J Cancer Res, 89, 719-726, 1998.
10. Oya M, Schulz W.A: Decreased expression of p57
KIP2
mRNA in human bladder cancer: Br J Cancer, 83,
626-631, 2000.
11. Nakashima J, Tachibana M, Horiguchi Y, Oya M, Ohigashi T, Asakura H, Murai M: Serum interleukin 6
as a prognostic factor in patients with prostate cancer: Clin Cancer Res, 6, 2702-2706, 2000.
12. Nakashima J, Ozu C, Nishiyama T, Oya M, Ohigashi T, Asakura H, Tachibana M, Murai M: Prognostic
value of alkaline phosphatase flare in patients with metastatic prostate cancer treated with endocrine
therapy: Urology, 56, 843-847, 2000.
13. Oya M, Ohtsubo M, Takayanagi A, Tachibana M, Shimizu N, Murai M: Constitutive activation of nuclear
fctor-B prevents TRAIL-induced apoptosis in renal cancer cells: Oncogene, 20, 3888-3896, 2001.
14. Horiguchi A, Oya M, Marumo K, Murai M: STAT3, but not ERKs mediates IL-6-induced proliferation of
renal cancer cells, ACHN and 769P: Kidney Int, 61, 926-938, 2002.
15. Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M: Activation of signal transducer and
activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological
features and clinical outcome: J Urol, 168, 762-765, 2002.
16. Horinaga M, Nakashima J, Ishibashi M, Oya M, Ohigashi T, Marumo K, Murai M: Clinical value of prostate
specific antigen based parameters for the detection of prostate cancer on repeat biopsy: the usefulness
of complicated prostate specific antigen adjustedfor transition zone volume: J Urol, 168, 986-990, 2002.
17. Marumo K, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Asakura H, Nakashima J, Murai M: Significance
and diagnostic accuracy of renal calculi found by ultrasonography in patients with asimptomatic microscopic
hematuria: Int J Urol, 9, 363-369, 2002.
18. Oya M, Takayanagi A, Horiguchi A, Mizuno M, Ohtsubo M, Marumo K, Shimizu N, Murai M: Increased
nuclear factor-B activation is related to the tumor development of renal cell carcinoma: Carcinogenesis,
24, 377-384, 2003.
19. Oya M, Horiguchi A, Mizuno M, Marumo K, Murai M: Increased activation of CCAAT/enhancer binding
protein-correlates with the invasiveness of renal cell carcinoma: Clin Cancer Res, 9, 1021-1027, 2003.
20. Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M: Elevated AKT activation and its impact
on clinicopathological features of renal cell carcinoma: J Urol, 169, 710-713, 2003.
21. Kikuchi E, Nakashima J, Horiguchi Y, Oya M, Ohigashi T, Murai M: Enhancement of Diethylstilbestrol induced
cytotoxicity by Bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancer: J
Urol, 169, 730-734, 2003.
22. Kikuchi E, Horiguchi Y, Nakashima J, Kuroda K, Oya M, Ohigashi T, Takahashi N, Shima Y, Umezawa K,
Murai M: Suppression of hormone-refractory prostate cancer bya novel nuclear factor B inhibitor in nude
mice: Cancer Res, 63, 107-110, 2003.
23. Horiguchi A, Nakashima J, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M:Prediction
of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score
in clinically localized prostate cancer: The Prostate, 56, 23-29, 2003.
24. Marumo K, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Asakura H, Nakashima J, Murai M: Incidence
and growth pattern of simple cysts of the kidney in patients with asymptomatic microscopic hematuria:
Int J Urol, 10, 63-67, 2003.
25. Schmidt B, Anastasiadis A.G, Seifert H.H, Franke K.H, Oya M, Ackermann R: Detection of circulating prostate
cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes
and high malignant grade: Anticancer Res, 23, 3991-3999, 2003.
26. Ito K, Nakashima J, Hanawa Y, Oya M, Ohigashi T, Marumo K, Murai M: The prediction of renal function
6 years after unilateral nephrectomy using preoperative risk factors: J Urol, 171, 120-125, 2004.
27. Mizuno R, Oya M, Shiomi T, Marumo K, Okada Y, Murai M: Inhibition of MKP-1 expression potentiates
JNK related apoptosis in renal cancer cells: J Urol, 172, 723-727, 2004.
28. Oya M, Mikami S, Mizuno M, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, Murai M
:Differential expression of activator protein-2 isoforms in renal cell carcinoma: Urology, 64, 162-167, 2004.
29. Nakashima J, Tanimoto A, Imai Y, Mukai M, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K,
Murai M: Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer:
Urology, 64, 101-105, 2004.
30. Ishizawa J, Yoshida S, Oya M, Mizuno R, Shinojima T, Marumo K, Murai M: Inhibition of the ubiquitin-proteasome
pathway activates stress kinases and induce apoptosis in renal cancer cells: Int J Oncol, 25, 697-702,
2004.
31. Kanao K, Kikuchi E, Nakashima J, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M:
Three-dimensional ultrasonography in evaluation of benign prostatic hyperplasia: Int J Urol, 11, 1087-1091,
2004.
32. Hara S, Oya M, Mizuno R, Horiguchi A, Marumo K, Murai M: Akt activation in renal cell carcinoma:
contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor: Ann
Oncol, 16, 928-933, 2005.
33. Oya M, Mikami S, Mizuno R, Marumo K, Mukai M, Murai, M: C-jun activation in acquired cystic kidney
disease and renal cell carcinoma: J Urol, 174, 726-730, 2005.
34. Mizuno R, Oya M, Hara S, Matsumoto M, Horiguchi A, Ohigashi T, Marumo K, Murai M: Modulation
of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd
5 in renal cancer cells: Oncol Rep, 14, 639-644, 2005.
35. Oya M, Asakura H, Mizuno R, Marumo K, Murai M: Repeated regression of pulmonary metastases from
renal cell carcinoma after treatment using different interferon-alpha preparations: Biomed Res, 26(3), 135-7,
2005.
36. Sato A, Oya M, Ito K, Mizuno R, Horiguchi Y, Ohigashi T, Umezawa K, Hayakawa M, Murai M: Survivin
associates with cell proliferation in renal cancer cells: Regulation of survivin expression by insulin-like
growth factor-1, interferon-gamma and a novel NF-kappaB inhibitor: Int J Oncol, 28, 841-846, 2006.
37. Mizuno R, Nakashima J, Mukai M, Ookita H, Nakagawa K, Oya M, Ohigashi, T, Marumo K, Murai M:
Maximum tumor diameter is a smple and valuable index associated with the local extent of disease
in clinically localized prostate cancer: Int J Urol, 13, 951-955, 2006.
38. Sato A, Ohigashi T, Oya M, Nakashima J, Marumo K, Murai M: Clinicopathological featurtes predicting
nodal metastasis of testicular seminoma: results from 100 cases in a single institute: Urol Int, 77, 64-68,
2006.
39. Mikami S, Oya M, Mizuno R, Murai M, Mukai M, Okada Y: Expression of Ets-1 in human clear cell renal
cell carcinomas: implications for angiogenesis: Cancer Sci, 97, 875-882, 2006.
40. Kikuchi E, Nakashima J, Ishibashi M, Ohigashi T, Oya M, Nakagawa K, Miyajima A, Murai M: Usefulness
of alpha 1-antichymotripsin-PSA complex for predicting bone metastases of prostate cancer: Urology, 68,
371-375, 2006.
41. Kanao K, Nakashima J, Nakagawa K, Asakura H, Miyajima A, Oya M, Ohigashi T, Murai M: Preoperative
nomograms for predicting stone-free rate after extracorporeal shock wave lithotripsy: J Urol, 176, 1453-1457,
2006.
42. Kikuchi E, Horiguchi Y, Nakashima J, Ohigashi T, Oya M, Nakagawa K, Miyajima A, Murai M: Assessment
of long-term quality of life using the FACT-BL questionnaire in patients with an ileal conduit, continent
reservoir, or orthotopic neobladder: Jpn J Clin Oncol, 36, 723-716, 2006.
43. Kuroda K, Nakashima J, Kanao K, Kikuchi E, Miyajima A, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T,
Murai M: Interleukin 6 is associated with cahexia in patients with prostate cancer: Urology, 69, 113-117,
2007.
44. Shinojima T, Oya M, Takayanagi A, Mizuno R, Shimizu N, Murai M: Renal cancer cells lacking hypoxia
inducible factor (HIF) 1-expression maintain vascular endothelial growth factor expression through HIF
2-: Carcinogenesis, 28, 529-536, 2007.
45. Nakashima J, Tanimoto A, Kikuchi E, Miyajima A, Nakagawa K, Oya M, Ohigashi T, Murai M: Clinical implications
of tumor size and local extent of primary prostatic lesions in prostate cancer patients with metastases:
value of endorectal magnetic resonance imaging in patients with metastases: Urology, 70:86-90, 2007.
46. Kosaka T, Mikami S, Miyajima A, Kikuchi E, Nakagawa K, Ohigashi T, Nakashima J, Oya M: Papillary renal
cell carcinoma: clinicopathological characteristics in 40 patients: Clin Exp Nephrol, 12,195-199, 2008.
47. Kosaka T, Miyajima A, Kikuchi E, Horiguchi Y, Umezawa K, Ohigasi T, Nakashima J, Asano T, Oya M: The
novel NF-kB activation inhibitor dehydroxymethy-epoxyquinomicin suppresses anti-thy1.1-induced
glomerulonephritis in rats: Nephron Exp Nephrol, 110, e17-e24, 2008.
48. Kanao K, Mikami S, Mizuno R, Shinojima T, Murai M, Oya M: Decreased acetylation of histone H3 in
renal cell carcinoma: a potential target of histone deacetylase inhibitors: J Urol, 180, 1131-1136, 2008.
49. Mikami S, Oya M, Shimoda M, Mizuno R, Ishida M, Kosaka T, Mukai M, Nakajima M, Okada Y: Expression
of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis: Clin Cancer Res,
14, 6055-6061, 2008.
50. Nishimoto K, Nakashima J, Hashiguchi A, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Oya M, Murai
M: Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy
gleason score in clinically localized prostate cancer: Int J Urol, 15, 520-523, 2008.
51. Ozu C, Nakashima J, Horiguchi Y, Oya M, Ohigashi T, Murai M: Prediction of bone metastases by combination
of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with
prostate cancer: Int J Urol, 15, 419-422, 2008.
52. Kanai K, Kikuchi E, Ohigashi T, Miyajima A, Nakagawa K, Nakashima J, Oya M: Gemcitabine and paclitaxel
chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based
chemotherapy.:Int J Clin Oncol, 13(6), 510-4, 2008.
53. Ide H, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M: The predictors of local recurrence
after radical cystectomy in patients with invasive bladder cancer: Jpn J Clin Oncol, 38(5), 360-4, 2008.
54. Nakashima J, Kikuchi E, Miyajima A, Nakagawa K, Oya M, Ohigashi T, Murai M: Simple stratification of
survival using bone scan and serum C-reactive protein in prostate cancer patients with metastases: Urol
Int, 80(2), 129-33, 2008.
55. Kikuchi E, Margulis V, Karakiewicz P, Mikami S, Lotan Y, Remzi M, Bolenz C, Zigeuner R, Weizer R, Montorsi
F, Bensalah K, Koppie TM, Fernandez MI, Wood CG, Roscigno M, Raman JD, Suardi N, Strobel P, Oya
M, ShariatSF: Lymphovascular invasion is a powerful predictor of clinical outcomes in patients with
node-negative uppertract urothelial carcinoma: J Clin Oncol, 27(4), 612-618, 2009.
56. Takeda T, Kikuchi E, Yuge K, Matsumoto K, Miyajima A, Nakagawa K, Oya M: Discontinuance of Bacille
Calmette-Guerin Instillation Therapy for Nonmuscle-Invasive Bladder Cancer Has Negative Effect on Tumor
Recurrence: Urology, 73(6), 1318-1322, 2009.
57. Kosugi M, Miyajima A, Kikuchi E, Kosaka T, Horiguchi Y, Murai M,
Oya M: Angiotensin II Type 1 Receptor Antagonist Enhances Cis-dichlorodiammineplatinum-Induced
Cytotoxicity in Mouse Xenograft Model of Bladder Cancer: Urology, 73(3), 655-660, 2009.
58. Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mochizuki S, Ikeda T, Mukai M, Okada
Y: Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas:
J Pathol, 218, 530-539, 2009.
59. Uchida Y, Miyajima A, Kikuchi E, Kozakai N, Kosaka T, Ieda M, Fkuda K, Ohigashi T, Oya M: Renal damage
inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction: Urology, 74(4),
938-943, 2009.
60. Ishida M, Nakashima J, Hashiguchi A, Mizuno R, Shinoda K, Kikuchi E, Miyajima A, Nakagawa K, Mukai
M, Oya M: Are predictive models for cancer volume clinically useful in localized prostate cancer?: Int
J Urol, 16, 936-940, 2009.
61. Bilim V, Ougolkov A, Yuuki K, Naito S, Kawazoe H, Muto A, Oya M, Billadeau D, Motoyama T, Tomita
Y: Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma: British Journal of Caner,
101, 1-10, 2009.
62. Kanai K, Nakashima J, Sugawara A, Shigematsu N, Nagata H, Kikuchi E, Miyajima A, Nakagawa K, Kubo
A, Oya M: Prediction of PSA bounce after permanent prostate brachytherapy for localized prostate cancer:
Int J Clin Oncol, 14(6), 502-6, 2009.
63. Hasegawa M, Kikuchi E, Yasumizu Y, Hattori S, Takeda T, Morita S, Kosaka T, Miyajima A, Horiguchi T,
Mikami S, Oya M: Brain metastasis of a papillary renal cell carcinoma, identified as type 2: Int J Clin
Oncol, 14(3), 270-2, 2009.
64. Miyajima A, Kikuchi E, Kosaka T, Oya M: Angiotensin II Type 1 Receptor Antagonist as an Angiogenic
Inhibitor in Urogenital Cancer: Rev Recent Clin Trials, 4(2), 75-8, 2009.
65. Mizuno R, Nakashima J, Mukai M, Okita H, Kosugi M, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T,
Oya M: Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical
prostatectomy in clinically localized prostate cancer: BJU Int, 104(9), 1215-8, 2009.
66. Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T: Clinical
outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered
bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association: Int J Urol,
16(3), 279-86, 2009.
67. Kanao K, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M: Preoperative
prognostic nomogram(probability table) for renal cell carcinoma based on TNM classification: J Urol, 181(2),
480-5, 2009.
68. Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Raman JD, Bolenz C, Bensalah
K, Koppie TM, Kassouf W, Fernandez MI, Strobel P, Wheat J, Zigeuner R, Langner C, Waldert M, Oya
M, Guo CC, Ng C, Montorsi F, Wood CG, Margulis V, Karakiewicz PI: Comparison of oncologic outcomes
for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases: Eur Urol,
53, 2799-2803, 2009.
69. Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Bolenz C, Remzi M, Weizer A, Zigeuner
R, Bensalah K, Ng CK, Raman JD, Kikuchi E, Monotorsi F, Oya M, Wood CG, Fernandez MI, Evans CP,
Koppie TM: Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the upper
tract urothelial carcinoma collaboration: J Urol, 182, 900-906, 2009.
70. Kosaka T, Miyajima A, Shirotake S, Kikuchi E, Hasegawa M, Mikami S, Oya M: Ets-1 and hypoxia inducible
factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer:
Prostate, 70(2), 162-9, 2010.
71. Kanai K, Kikuchi E, Mikami S, Suzuki E, Uchida Y, Kodaira K, Miyajima A, Ohigashi T, Nakashima J, Oya
M: Vitamin Esuccinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder
cancer cells in vitro and in vivo: Cancer Sci, 101(1), 216-223, 2010.
72. Ide H, Kikuchi E, Kono H, Nagata H, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M: Docetaxel
in combination with prednisolone for hormone refractory prostate cancer: Jpn J Clin Oncol, 40(1), 79-84,
2010.
73. Matsumoto K, Kikuchi E, Horiguchi Y, Tanaka N, Miyajima A, Nakagawa K, Nakashima J, Oya M: Late
Recurrence and Progression in Non-muscle-invasive Bladder Cancers After 5-year Tumor-free Periods: Urology,
75(6), 1385-1391, 2010.
74. Ide H, Nakashima J, Kono H, Kikuchi E, Nagata H, Miyajima A, Nakagawa K, Oya M: Prognostic Stratification
in Patients Who Received Hormonal Therapy for Prostate-specific Antigen Recurrence after Radical
Prostatectomy: Jpn J Clin Oncol, 40(2), 177-80, 2010.
75. Ishida M, Mikami S, Kikuchi E, Kosaka T, Miyajima A, Nakagawa K, Mukai M, Okada Y, Oya M: Activation
of the Aryl hydrocarbon receptor pathway enhances cancer cell invasion by up-regulating the MMP expression
and is associated with poor prognosis in upper urinary tract urothelial cancer: Carcinogenesis, 31(2), 287-95,
2010.
76. Ohigashi T, Kanao K, Mizuno R, Kikuchi E, Nakashima J, Oya M: Predicting the probability of significant
prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: Development
of a novel pre-biopsy nomogram: Int J Urol, 17, 274-280, 2010.
77. Kodaira K, Kikuchi E, Kosugi M, Horiguchi Y, Matsumoto K, Kanai K, Suzuki E, Miyajima A, Nakagawa
K, Tachibana M, Umezawa K, Oya M: Potent cytotoxic effect of a novel nuclear factor-kB inhibitor
dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines: Urology,
75(4), 805-812, 2010.
78. Nishimoto K, Nakagawa K, Li D, Kosaka T, Oya M, Mikami S, Shibata H, Itoh H, Mitani F, Yamazaki T,
Ogishima T, Suematsu M, Mukai K: Adrenocortical zonation in humans under normal and pathological
conditions: J Clin Endocrinol Metab, 95(5), 2296-2305, 2010.
79. Yoshimine S, Kikuchi E, Matsumoto K, Ide H, Miyajima A, Nakagawa K, Oya M: The clinical significance
of urine cytology after a radical cystectomy for urothelial cancer: Int J Urol, 17(6), 527-533, 2010.
80. Miyajima A, Hasegawa M, Takeda T, Tamura K, Kikuchi E, Nakagawa K, Oya M: How do young residents
practice laparoscopic surgical skills?: Urology, 76(2), 352-356, 2010.
81. Kaiho Y, Kikuchi E, Oya M, Yoshioka K, Nakagami Y, Hatano T, Ozu C, Horiguchi Y, Namiki K, Tachibana
M, Hisasue S, Tanaka N, Asakawa I: Report of the international Journal of Urology editorial board meeting
2010 in Iwate Haruki Kume characteristics and management of erectile dysfunction after various treatments
for prostate cancer Jintetsu Soh: Int J Urol, 17(8), 686-688, 2010.
82. Naito S, Tomita Y, Sun Young Rha, Uemura H, Oya M, He Zhi Song, Li Han Zhong, Mohamed Ibrahim
Bin A Wahid: Kidney cancer working group report: Jpn J Clin Oncol, 40, i51-i56, 2010.
83. Tanaka N, Miyajima A, Kosaka T, Shirotake S, Hasegawa M, Kikuchi E, Oya M: Cis-dichlorodiammineplatinum
upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances
VEGF production in bladder cancer: Mol Cancer Ther, 9(11), 2982-2992, 2010.
84. Maeda T, Kikuchi E, Matsumoto K, Yazawa S, Hagiuda J, Miyajima A, Nakagawa K, Fujiwara H, Hoshino
H, Oya M: Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy
syndrome in a bladder cancer patient: Int J Clin Oncol, 15(5), 508-511, 2010.
85. Raman JD, Ng CK, Scherr DS, Margulis V, Lotan Y, Bensalah K, Patard JJ, Kikuchi E, Montorsi F, Zigeuner
R, Weizer A, Bolenz C, Koppie TM, Isbarn H, Jeldres C, Kabbani W, Remzi M, Waldert M, Wood CG,
Roscigno M, Oya M, Langner C, Wolf JS, Strobel P, Fernandez M, Karakiewcz P, Shariat SF: Impact of
tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical
nephroureterectomy: Eur Urol, 57(6), 1072-1079, 2010.
86. Yoshimine S, Miyajima A, Nakagawa K, Ide H, Kikuchi E, Oya M: Extraperitoneal Approach Induces Postoperative
Inguinal Hernia Compared with Transperitoneal Approach after Laparoscopic Radical Prostatectomy: Jpn
J Clin Oncol, 40(4), 349-352, 2010.
87. Shirotake S, Kikuchi E, Matsumoto K, Yazawa S, Kosaka T, Miyajima A, Nakagawa K, Oya M: Role of Pelvic
Lymph Node Dissection in Lymph Node-Negative Patients with Invasive Bladder Cancer: Jpn J Clin Oncol,
40(3), 247-251, 2010.
88. Kaneko G, Kikuchi E, Hasegawa M, Miyajima A, Nakagawa K, Kameyama K, Oya M: Non-muscle invasive
bladder cancer with concomitantvaginal urothelial carcinoma: a case report and review of the literature:
Int J Clin Oncol, 15, 626-630, 2010.
89. Kosaka T, Kikuchi E, Mikami S, Miyajima A, Shirotake S, Ishida M, Okada Y, and Oya M: Expression of
Snail in upper urinary tract urothelialcarcinoma: Prognostic significance and implications for tumor invasion:
Clin Cancer Res, 16(23), 5814-5823, 2010.
90. Yuge K, Miyajima A, Hasegawa M, Miyazaki Y, Maeda T, Takeda T, Takeda A, Miyashita K, Kurihara I,
Shibata H, Kikuchi E, Oya M: Initial experience of transumbilical laparoendoscopic single-site surgery of
partial adrenalectomy in patient withaldosterone-producing adenoma: BMC Urol, 10, 19, 2010.
91. Sugawara A, Nakashima J, Kunieda E, Nagata H, Asakura H, Oya M, Shigematsu N: Preimplant factors
affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal
interstitial prostate brachytherapy with 125I free seeds: Radiat Oncol, 5,86, 2010.
92. Matsushima M, Kikuchi E, Hasegawa M, Matsumoto K, Miyajima A, Oya M: Clinical impact of bladder
biopsies with TUR-BT according to cytology results in patients with bladder cancer: a case control study:
BMC Urol, 10, 12, 2010.
93. Matsumoto K, Nakagawa K, Hashiguchi A, Kono H, Kikuchi E, Nagata H, Miyajima A, Oya M: Contrast-enhanced
ultrasonography of the prostate with Sonazoid: Jpn J Clin Oncol, 40(11), 1099-104, 2010.
94. Shinoda K, Nakagawa K, Kosaka T, Tanaka N, Maeda T, Kono H, Mizuno R, Kikuchi E, Miyajima A, Umezawa
K, Oya M: Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor,
dehydroxymethylepoxyquinomicin: Hum Immunol, 71(8), 763-70, 2010.
95. Tanaka N, Kikuchi E, Matsumoto K, Miyajima A, Nakagwa K, Oya M: Frequency of tumor recurrence:
A strong predictor of stage progression in initially diagnosed nonmuscle invasive bladder cancer: J Urol,
185(2), 450-455, 2011.
96. Hayakawa N, Kikuchi E, Mikami S, Matsumoto K, Miyajima A, Oya M: The Clinical Impact of the Classification
of Carcinoma In Situ on Tumor Recurrence and their Clinical Course in Patients with Bladder Tumor:
Jpn J Clin Oncol, 42(3), 424-429, 2011.
97. Hagiwara M, Miyajima A, Matsumoto K, Kikuchi E, Nakagawa K, Oya M: Benefit of Laparoscopic Radical
Nephrectomy in Patients with a High BMI:Jpn J Clin Oncol, 41(3), 400-4, 2011.
98. Nagamatsu G, Kosaka T, Kawasumi M, Kinoshita T, Takubo K, Akiyama H, Sudo T, Kobayashi T, Oya M,
Suda T: A germ cell specific gene, Prmt5 works as somatic cell reprogramming: J Biol Chem, 286(12),
10641-10648, 2011.
99. Maeda T, Kikuchi E, Matsumoto K, Miyajima A, Oya M: Urinary pH is highly associated with tumor recurrence
during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor: J Urol, 185(3), 802-806,
2011.
100. Yuge K, Kikuchi E, Matsumoto K, Takeda T, Miyajima A, Oya M: Could Patient Age Influence Tumor Recurrence
Rate in Non-muscle-invasive Bladder Cancer Patients Treated with BCG Immunotherapy? :Jpn J Clin Oncol,
41(4), 565-570, 2011
101. Shirotake S, Miyajima A, Kosaka T, Tanaka N, Maeda T, Kikuchi E, Oya M: Angiotensin II type 1 receptor
expression and microvessel density in human bladder cancer: Urology, 77(4), 1009-1010, 2011.
102. Ide H, Kikuchi E, Yasumizu Y, Hattori S, Hasegawa M, Miyajima A, Oya M: Combination treatment of
S-1 with CPT-11 to overcome 5-fluorouracil resistance in bladder cancer: Jpn J Clin Oncol, 41, i4-i5, 2011.
103. Kaneko G, Kikuchi E, Matsumoto K, Obata J, Nakamura S, Miyajima A, Oya M: Neoadjuvant gemcitabine
plus cisplatin for muscle-invasive bladder cancer: Jpn J Clin Oncol, 41(7), 908-14, 2011.
104. Matsumoto K, Kikuchi E, Horinaga M, Takeda T, Miyajima A, Nakagawa K, Oya M: Intravesical Interleukin-15
Gene Therapy in an Orthotopic Bladder Cancer Model:Hum Gene Ther, 22(11), 1423-32, 2011.
105. Kosaka T, Miyajima A, Shirotake S, Suzuki E, Kikuchi E, Oya M: Long-term androgen ablation and docetaxel
up-regulate phosphorylated Akt in castration resistant prostate cancer:J Urol, 185(6), 2376-81, 2011.
106. Suda N, Shibata H, Kurihara I, Ikeda Y, Kobayashi S, Yokota K, Murai-Takeda A, Nakagawa K, Oya M,
Murai M, Rainey WE, Saruta T, Itoh H: Coactivation of SF-1-mediated transcription of steroidogenic enzymes
by Ubc9 and PIAS1:Endocrinology, 152(6), 2266-77, 2011.
107. Ito Y, Kikuchi E, Tanaka N, Miyajima A, Mikami S, Jinzaki M, Oya M: Preoperative hydronephrosis grade
independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper
tract urothelial carcinoma:J Urol, 185(5), 1621-6, 2011.
108. Kosaka T, Miyajima A, Shirotake S, Kikuchi E, Oya M: Phosphorylated Akt up-regulates angiotensin II type-1
receptor expression in castration resistant prostate: Prostate, 71(14), 1510-7, 2011.
109. Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mukai M, Okada Y: Expression of snail
and slug in renal cell carcinoma: E-cadherin repressor snail is associated with cancer invasion and prognosis:
Lab Invest, 91, 1443-1458, 2011.
110. Kosaka T, Oya M: History and current review of basic research for prostate cancer :Nihon Rinsho,69,
Suppl 5, 7-12,2011.
111. Tanaka N, Miyajima A, Kikuchi E, Matsumoto K, Hagiwara M, Ide H, Kosaka T, Masuda T, Nakamura
S, Oya M: Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial
carcinoma: British Journal of Cancer, 106, 290-296, 2011.
112. Hasegawa M, Miyajima A, Kosaka T, Yasumizu Y, Tanaka N, Maeda T, Shirotake S, Ide H, Kikuchi E, Oya
M: Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant
prostate cancer: Int J Cancer, 130(2), 431-42, 2012
113. Sugawara A, Nakashima J, Kunieda E, Nagata H, Mizuno R, Takeda A, Seki S, Shiraishi Y, Kouta R, Oya
M, Shigematsu N:
Preimplant factors affecting Prostate D90 after transperineal interstitial prostate
brachytherapy with loose(125) I seeds : Keio J Med, 61(3), 89-94, 2012.
114. Yazawa S, Kikuchi E, Takeda T, Matsumoto K, Miyajima A, Nakagawa K, Oya M: Surgical and chemotherapeutic
options for urachal carcinoma: report of ten cases and literature review: Urol Int, 88(2), 209-14, 2012.
115. Mizuno R, Oya M: Biomarker for molecular targeting therapy against renal cell carcinoma: Gan To Kagaku
Ryoho, 39(1), 39-42, 2012.
116. Tanaka N, Miyajima A, Kikuchi E, Matsumoto K, Hagiwara M, Ide H,Kosaka T, Masuda T, Nakamura S,
Oya M: Prognonstic impact of renin-angiotensin system blockade in localized upper-tract urothelial carcinoma:
Br J Cancer,106(2),290-6,2012.
117. Tsujioka Y, Jinzaki M, Tanimoto A, Nakagawa K, Akita H, Kikuchi E, Okuda S, Mikami S, Oya M, Kuribayashi
S.:Radiological findings of primary localized amyloidosis of the ureter: J Magn Reson Imaging, 35(2),431-5,
2012.
118. Oya M: What do we need for eradicating kidney cancer cells?: Int J Urol,19(2),96-7,2012.
119. Hoshino K, Kikuchi E, Tanaka N, Akita H, Ito Y, Miyajima A, Jinzaki M, Oya M : Preoperative hydronephrosis:
independent predictor for changes in renal function following nephroureterectomy.: Jpn J Clin Oncol,
42(3), 202-7, 2012.
120. Shirotake S, Miyajima A, Kosaka T, Tanaka N, Kikuchi E, Mikami S, Okada Y, Oya M: Regulation of monocyte
chemoattractant protein-1 through angiotensin ll type 1 receptor in prostate cancer: Am J Pathol, 180(3),
1008-16, 2012.
121. Takeda T, Kikuchi E, Mikami S, Suzuki E, Matsumoto K, Miyajima A, Okada Y, Oya M: Prognostic role
of KiSS-1 and possibility of therapeutic modality of metastin,the final peptide of the KiSS-1 gene, in
urothelial carcinoma: Mol Cancer Ther,11(4),853-63, 2012.
122. Shirakawa H, Kikuchi E, Mikami S, Fukamachi S, Miyazaki Y, Tanaka N, Miyajima A, Oya M: Three cases
of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas: Scand J Urol
Nephrol,46(2),136-41,2012.
123. Miyajima A, Hattori S, Maeda T, Hasegawa M, Takeda T, Kikuchi E, Asanuma H, Nakagawa K, Oya M:
Transumbilical approach for short-term outcome: Int J Urol,19(4),331-5,2012.
124. Matsumoto K, Kikuchi E, Shirakawa H, Hayakawa N, Tanaka N, Ninomiya A, Miyajima A, Nakamura S,
Oya M: Risk of subsequent tumour recurrence and stage progression in bacilli Calmette-Guerin relapsing
non-muscle-invasive bladder cancer: BJU Int, 110(11 Pt B), E508-13, 2012.
125. Mizuno R, Asano K, Mikami S, Nagata H, Kaneko G, Oya M: Patterns of interstitial lung disease during
everolimus treatment in patients with metastatic renal cell carcinoma: Jpn J Clin Oncol, 42(5), 442-6,
2012.
126. Nagamatsu G, Kosaka T, Saito S, Takubo K, Akiyama H, Sudo T, Horimoto K, Oya M, Suda T: Tracing
the conversion process from primordial germ cells to pluripotent stem cells in mice: Biol Reprod, 86(6),
182, 2012.
127. Kaneko G, Miyajima A, Kikuchi E, Nakagawa K, Oya M: The benefit of laparoscopic partial nephrectomyin
high body mass index patients: Jpn J Clin Oncol, 42(7), 619-24, 2012.
128. Miyazaki Y, Kosaka T, Mikami S, Kikuchi E, Tanaka N, Maeda T, Ishida M, Miyajima A, Nakagawa K, Okada
Y, Sato Y, Oya M: The prognostic significance of vasohibin-1 expression inpatients with upper urinary
tract urothelial carcinoma: Clin Cancer Res, 18(15), 4145-53, 2012
129. Kozakai N, Kikuchi E, Hasegawa M, Suzuki E, Ide H, Miyajima A, Horiguchi Y, Nakashima J, Umezawa
K, Shigematsu N, Oya M: Enhancement of radiosensitivity by a unique noel NF-κB inhibitor, DHMEQ,
in prostate cancer: Br J Cancer, 107(4), 652-7, 2012.
130. Miyazaki Y, Miyajima A, Maeda T, Ito Y, Tanaka N, Kosaka T, Masuda A, Mizuno R, Kikuchi E, Nakagawa
K, Oya M: Renal cell carcinoma arising from a horseshoe kidney in a chronic hemodialysis patient: Clin
Exp Nephrol, 16(4), 647-51, 2012.
131. Shirakawa H, Kikuchi E, Tanaka N, Matsumoto K, Miyajima A, Nakamura S, Oya M: Prognostic significance
of Bacillus Calmette-Guerin failure classification in non-muscle-invasive bladder cancer: BJU Int,110(6 Pt
B), E216-21, 2012.
132. Suzuki K, Mizuno R, Mikami S, Tanaka N, Kanao K, Kikuchi E, Miyajima A, Nakagawa K, Oya M: Prognostic
significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma: Jpn J Clin Oncol,
42(9), 831-5, 2012.
133. Fukada J, Shigematsu N, Nakashima J, Ohashi T, Kawaguchi O, Oya M: Predicting pubic arch interference
in prostate brachytherapy on transrectal ultrasonography-computed tomography fusion images: J Radiat
Res, 53(5), 753-9, 2012.
135. Ito Y, Kikuchi E, Maeda T, Matsushima M, Kono H, Mizuno R, Nagata H, Miyajima A, Nakagawa K, Oya
M: Bone scan in patients with newly diagnosed prostate cancer ; To perform or not? : External validation
of the currently available guidelines for Japanese patients: The108th American Urological Association Annual
Meeting: San Diego: 2013. 5.
th
136. Oya M "FHormonal micro-environment of castration resistant prostate cancer: 10 German-Japanese Urological
Meeting: Kyoto:2013.6.
th
137. Oya M: Resistance to angiogenesis inhibitors in metastatic renal cell carcinoma: The 11 Annual Meeting
of Japanese Society of Medical Oncology: Miyagi: 2013.8.
138. Mizuno R, Asanuma H, Kono H, Shinojima T, Kikuchi E, Miyajima A, Nakagawa K, Oya M, Mikami S:
Clinical Experience of Xp11:2 Translocation Renal Cell Carcinoma: 33
rd
CONGRESS OF THE SOCIETE
INTERNATIONALE D’ UROLOGIE : VANCOUVER: 2013.9.
th
139. Oya M: Speaker: SymposiumⅢRole of Androgens From Male Development to Male LUTS: The 4 Congress
of Asian Pacific Prostate Society: Okinawa: 2014.3.
140. Yasumizu Y, Miyajima A, Kosaka T, Miyazaki Y, Kikuchi E, Oya M: Dual Phosphatidylinositol-3-Kinase/Mammalian
Target of Rapamycin Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer:
The 4th Congress of Asian Pacific Prostate Society: Okinawa: 2014.3.
141. Shinojima T, Mizuno R, Kosaka T, Kikuchi E, Miyajima A, Oya M, D.S.B.Hoon, L.Lessard.: Combinational
epigenetic therapy targeting EZH2 and histone deacetylase in prostate cancer cells: Synergic effect on
induction of apoptosis and TIMP3 tumor suppressor gene:29
th
Annual EAU Congress:Stockholm:2014.4.
142. Oya M :Chairs:Poster Session 53:Renal function and survival after partial nephrectomy: 29th Annual EAU
Congress:Stockholm:2014.4.
143. Kaneko G, Miyajima A, Hasegawa R, Mizuno R, Uchida Y, Hara S, Kikuchi E, Nakagawa K, Jinzaki M,
Oya M: Visceral obesity is a useful predictor of better recurrence-free survival after curative surgeries
for Japanese patients with localized clear cell renal cell carcinoma: 29th Annual EAU Congress: Stockholm:
2014.4.
144. Hak Lee, Ithaar Derweesh, Song Wang, Ramzi Jabaji, Kyle Gilis, La Jolla, Riccardo Autorino, Luis Brandao,
S.Jeff Chueh, Jihad Kaouk, Cleveland, Yinghao Sun, Bo Yang, Guo Fei, Shanghai, Deok Hyun, Byong Chang
Jeong, Seoul, Francesco Greco, Vincenzo Altieri, Rocca di Neto, Paolo Fornara, Halle Saale, Luca Cindolo,
Francesco Berardinelli, Luigi Schips, Vasto, Christian Fiori, Francesco Porpiglia, Orbassano, Xiang Chen,
Zhi Chen, Yao He, Changsha, Anibal Branco, Curitiba, Chun-Hou Liao, lason Kyriazis, Evangelos Liatsikos,
Patra, Greece, Miyajima A, Oya M: Contemporary minimally invasive management of adrenal disorders:
an international multi-institutional Survey: AUA Annual Meeting: Orlando: 2014.5.
145. Hongo H, Shinojima T, Yazawa S, Kanao K, Morita S, Kosaka T, Kono H, Mizuno R, Kikuchi E, Nagata
H, Asanuma H, Miyajima A, Nakagawa K, Saito S, Oya M: Development of an algorithm for predicting
severe acute epididymitis: AUA Annual Meeting: Orlando: 2014.5.
146. Ito Y, Kikuchi E, Tanaka N, Kosaka T, Mizuno R, Miyajima A, Umezawa K, Oya M: Up-Regulated NFkB
Activation is apotent therapapeutic target in acquired platinum-resistant bladder cancer: the efficacy of
NFkB blockade by dehydroxymethyl derivative of epoxyquinomicin(DHMEQ): AUA Annual Meeting: Orlando:
2014.5.
147. Yoshimine S, Kikuchi E, Kosaka T, Miyajima A, Oya M: Therapapeutic effect by targeting BCL-XL protein
in urothelial carcinoma cells: AUA Annual Meeting: Orlando: 2014.5.
148. Kosaka T, Nagamatsu G, Mikami S, Miyajima A, Yasumizu Y, Miyazaki Y, Kikuchi E, Saito S, Horimoto
K, Suda T, Okada Y, Oya M: Drug efficacy reprogramming by ribavirin against the cancer stemness in
Docetaxel-Resistant prostate cancer: AUAAnnual Meeting: Orlando: 2014.5.
149. Yasumizu Y, Kosaka T, Miyazaki Y, Kikuchi E, Miyajima A, Oya M: Metabolic shift under hypoxic environment
causes resistance to mtor inhibitor in human castration resistant prostate cancer: AUA Annual Meeting:
Orlando: 2014.5.
150. Hattori S, Kikuchi E, Kosaka T, Miyajima A, Mikami S, Oya M: AXL is a novel prognostic marker in upper
urinary tract urothelial carcinoma: AUA Annual Meeting: Orlando: 2014.5.
151. Ishida M, Mikami S, Kosaka T, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Okada Y, Oya M: Increased
expression of aryl hydrocarbon receptor in clear cell renal cell carcinoma and infiltrating lymphocytes:
Implications for cancer invasion, prognosis and tumor immunity: AUA Annual Meeting: Orlando: 2014.5.
152. Mikami S, Mizuno R, Kosaka T, Saya H, Oya M, Okada Y: Prognostic significance of TNF-a and CD44
expression in crear cell renal cell carcinomas: implication of cancer invasion, metastasis, and resistance
to sunitinib treatment: AUA Annual Meeting: Orlando: 2014.5.
153. Matsushima M, Kikuchi E, Maeda T, Ando T, Nagata H, Miyajima A, Nakagawa K, Oya M: Erectile function
is highly associated with prostate-specific antigen bounce in localized prostate cancer patients treated
with permanent prostate brachytherapy: AUA Annual Meeting: Orlando: 2014.5.
154. Yuge K, Kikuchi E, Hagiwara M, Yasumizu Y, Kosaka T, Miyajima A, Oya M: Nicotine induces tumor aggressiveness
and chemoresistance through activation of Pl3K/AKT/MTOR pathway in bladder cancer: AUA Annual Meeting:
Orlando: 2014.5.
155. Hagiwara M, Kikuchi E, Kosaka T, Yuge K, Yasumizu Y, Saya H, Oya M: Metformin is a new therapeutic
strategy for targeting CD44 variant in bladder cancer: AUA Annual Meeting: Orlando: 2014.5.
156. Yasumizu Y, Kosaka T, Miyazaki Y, Kikuchi E, Miyajima A, Oya M: Post-translational modification mediated
by the prolyl isomerase PIN1 accerelate cancer progression incastration resistant prostate cancer: AUA
Annual Meeting: Orlando: 2014.5.
157. Fukumoto K, Kikuchi E, Mikami S, Matsushima M, Yuge K, Ogiwara K, Miyajima A, Nakagawa K, Oya
M: Impact of lymphovascular invasion status in transurethral resection of bladder tumors could predict
subsequent stage progression in T1 bladder tumors: AUA Annual Meeting: Orlando: 2014.5.
158. Kobayashi H, Kikuchi E, Maeda T, Tanaka N, Matsumoto K, Miyajima A, Nakagawa K, Nakamura S, Oya
M: Timing of 1st recurrence affects subsequent clinical outcome in 1st recurrent low grade ta bladder
cancer: AUA Annual Meeting: Orlando: 2014.5.
159. Ishioka K, Kikuchi E, Maeda T, Hasegawa M, Kosaka T, Shinojima T, Nagata H, Miyajima A, Nakagawa
K, Oya M: Prosrective evaluation of efficacy and safety of solifenacin and mirabegron treatment in BPH
patients treated with dutasteride but having OAB symptoms: AUA Annual Meeting: Orlando: 2014.5.
160. Matsumoto K, Mizuno R, Tanaka N, Ide H, Hasegawa M, Ishida M, Hayakawa N, Yasumizu Y, Hagiwara
M, Hara S, Kikuchi E, Miyajima A, Nakagawa K, Nakajima Y, Nakamura S, Nakashima J, Oya M: Optimal
timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy: AUA Annual
Meeting: Orlando: 2014.5.
161. Yazawa S, Yamamoto H, Shimada M, Kaburaki N, Shinojima T, Koyama M, Takeyama M, Kato K, Sho
T, Kiyota H, Iwata S, Oya M, Matsymoto T: Nationwide survey on periorerative management and surgical
site infection of patients who underwent transvaginal mesh for treatment of pelvic organ prolapse: AUA
Annual Meeting: Orlando: 2014.5.
162. Obata J, Kikuchi E, Tanaka N, Shirotake S, Matsumoto K, Oyama M, Kanao K, Kobayashi H, Miyazaki
Y, Ide H, Ishioka K, Miyajima A, Momma T, Nakagawa K, Oya M: The predictive value of C-REACTIVE
protein for prognosis in patients with metastatic upper tract urothelial carcinoma treated with
CISPLATIN-BASED chemotherapy following radical nephroureterectomy: MULTI-INSTITUTIONAL study: AUA
Annual Meeting: Orlando: 2014.5.
163. Mizuno R , Kosaka T, Mikami S, Oya M Efficacy of axitinib in patients with metastatic renal cell carcinoma
previously treated with both VEGFR-TKI and mTORI.: 2014 ASCO Annual Meeting: Chicago:2014.5.
164. Kosaka T, Miyazaki Y, Miyajima A, Mizuno R, Mikami S, Daimon T, Kikuchi E, Nakagawa K, Sato Y, Oya
M The prognostic significance of vasohibin-1 expression in patients with prostate cancer.: 2014 ASCO
Annual Meeting: Chicago:2014.5.
165. Daimon T, Kosaka T, Mikami S, Miyazaki Y, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Sabe H, Oya
M Erythrocyte protein band 4.1-like5 expression in patients with upper urinary tract urothelial carcinoma
correlates with tumor recurrence.: 2014 ASCO Annual Meeting: Chicago:2014.5.
166. Miura Y, Chiyo K, Imamura, Uchino K, Kishida T, Matsubara N, Shinojima T, Oya M, Nakaigawa N, Yoshimura
K, Takano T, Tanigawara Y; Dose adjustment of axitinib based on AUC monitoring in sunitinib-refractory
advanced renal cell carcinoma.: 2014 ASCO Annual Meeting: Chicago:2014.5.
167. M Oya:Chairs: Poster Session 34: Imaging in the management of renal tumours: 30th Annual EAU Congress:
Madrid: 2015.3.
168. Matsumoto K, Hayakawa N, Morita S, Shinoda K, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma
H, Miyajima A, Oya M: Bladder metastasis from renal cell carcinoma: Retrospective analysis of 65 reported
cases: 30th Annual EAU Congress: Madrid: 2015.3.
169. Fukumoto K, Miyajima A, Hattori S, Morita S, Shinoda K, Kosaka T, Mizuno R, Shinojima T, Kikuchi E,
Asanuma H, Jinzaki M, Oya M: What changed after mastering surgical skills in laparoendoscopic single-site
adrenalectomy?: 30th Annual EAU Congress: Madrid: 2015.3.